carbazilquinone has been researched along with Lymphoma of Mucosa-Associated Lymphoid Tissue in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takenaka, T | 1 |
| Maruyama, K | 1 |
| Kinoshita, T | 1 |
| Sasako, M | 1 |
| Sano, T | 1 |
| Katai, H | 1 |
| Matsuno, Y | 1 |
1 trial available for carbazilquinone and Lymphoma of Mucosa-Associated Lymphoid Tissue
| Article | Year |
|---|---|
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Che | 1997 |